4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-20-007719
President and CEO sold 745 shares at $4.03 ($3,002)
- President and CEO acquired 1,786 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sanjay President and CEO | 2020-02-06 | Option exercise | +1,786 | 2,036 | D | ||
| Shukla Sanjay President and CEO | 2020-02-07 | Sale | −745 | $4.03 | $3,002 | 1,291 | D |
| Derivatives | |||||||
| Shukla Sanjay President and CEO | 2020-02-05 | Grant or award · Employee Stock Option (right to buy) | +39,327 | 39,327 | D | ||
| Shukla Sanjay President and CEO | 2020-02-06 | Option exercise · Restricted Stock Unit | −1,786 | 1,786 | D | ||
| Open-market sales · 745 sh · avg $4.03 · $3,002 | |||||||
Loading xslF345X03/doc4.xml…